Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
100 results
100063 - Nasal ST2⁺ regulatory T cells restrain Tc1-Neutrophil axis in 1 chronic rhinosinusitis
100109 - Toxic epidermal necrolysis due to fosfomycin
100110 - Perioperatives reaction to morphine
100138 - Diagnostic Value of Mixed Iodinated Contrast Media Skin Testing in Patients with Radiocontrast Media Hypersensitivity
100141 - Assessing the Safety, Effectiveness, and Impact of Community Pharmacy Penicillin Allergy Delabelling Service in Hong Kong: A Pilot Study
100163 - Comparison Of Clinical Features In Primary Immunodeficiency Patients With And Without Autoimmunity Or Autoinflammation
100186 - Something Fishy: Recurrent Angioedema Triggered by Environmental Exposure to Fish Allergens
100197 - Upper and Lower Airway Diseases: Current Phenotypes and Integrated Treatment Approaches
100199 - Availability of skin-friendly personal protective equipment for healthcare workers with atopic dermatitis: a hospital-wide audit
100228 - Soluble CD25 as a marker of immune activation in pediatric asthma: a prospective case-control study
100230 - Lack of association between plasma interleukin-6 levels and pediatric asthma severity
100243 - Liver Transplantation in a Patient with Primary Immunodeficiency and Cirrhosis: A Clinical Evaluation
100252 - Particulate Matter Co-Exposure with Indoor Airborne Bacteria Synergistically Exacerbates Allergic Rhinitis and Pulmonary Toxicity in Mice
100276 - Allergic Bronchopulmonary Aspergillosis Masked by Asthma and Recurrent Pneumonia
100284 - Tolerance to iodixanol after anaphylaxis due to iohexol, guided by Basophil Activation Test
100290 - Method of the severity of asthma exacerbation evaluation by the Integral indicator
100302 - Improvement in Atopic Dermatitis Signs and Symptoms With Once-Daily and Proactive Twice-Weekly Roflumilast Cream 0.15% or 0.05%: 52-Week Phase 3 INTEGUMENT-OLE Trial Outcomes in Patients Aged ≥2 Years
100373 - “Refractory Chronic Spontaneous Urticaria to Conventional Treatment: Challenges and Therapeutic Strategies”
100383 - When the sun is not the only culprit: Persistent Th2-driven hydrochlorothiazide-induced photoallergic dermatitis responding to dupilumab
100384 - Altered CD4⁺ T Helper cell subsets in children with Severe Asthma: A focus on Th1, Th2, and Th17 Cells
Pagination
First page
First
Previous page
Previous
Page
1
Page
2
Page
3
Current page
4
Page
5
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download